Onesource Specialty Pharma - Share Price & Details
2 Week Avg Qty
0.61(Lakh)
Circuit Limit
17,683.00/1,139.85
Broker Recommendations
| Date |
Author |
Type |
Reco Price |
Target Price |
Potential |
Source |
PDF Link |
| 13 Nov 2025 |
ICICI Securities |
Buy |
₹1,728.75 |
₹2,475 |
43.4% |
moneycontrol |
View |
| 06 Aug 2025 |
ICICI Securities |
Buy |
₹1,875.05 |
₹2,475 |
32% |
moneycontrol |
View |
Peer Comparison
About Onesource Specialty Pharma
Onesource Specialty Pharma Limited is listed on NSE.
Quarterly Table
| Metrics | Dec 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
| Sales | 336.7 | 336.7 | 477.4 | 321.0 | 375.2 |
|---|
| Expenses | 236.4 | 236.4 | 240.4 | 241.1 | 273.6 |
|---|
| Operating Profit | 100.4 | 100.4 | 237.0 | 79.9 | 101.6 |
|---|
| OPM % | 29.81% | 29.81% | 49.64% | 24.88% | 27.07% |
|---|
| Other Income | -95.5 | -95.5 | 3.9 | 5.3 | 3.0 |
|---|
| Interest | 43.9 | 43.9 | 32.4 | 27.0 | 33.3 |
|---|
| Depreciation | 34.0 | 34.0 | 33.6 | 33.3 | 34.2 |
|---|
| Profit before tax | 27.5 | 27.5 | 174.9 | 24.8 | 37.1 |
|---|
| Tax % | 0% | 0% | 0% | 0% | 0% |
|---|
| Net Profit | -73.0 | -73.0 | 174.2 | 24.8 | 37.1 |
|---|
| EPS in Rs | -6.69 | -6.69 | 0 | 2.16 | 3.24 |
|---|
| Metrics | Dec 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 |
|---|
| Sales | 392.6 | 392.6 | 426.0 | 375.8 | 290.3 |
|---|
| Expenses | 249.3 | 249.3 | 243.4 | 269.3 | 273.0 |
|---|
| Operating Profit | 143.2 | 143.2 | 182.6 | 106.5 | 17.3 |
|---|
| OPM % | 36.48% | 36.48% | 42.86% | 28.34% | 5.97% |
|---|
| Other Income | -95.1 | -95.1 | 2.9 | 3.0 | -2.5 |
|---|
| Interest | 45.8 | 45.8 | 33.4 | 34.0 | 38.2 |
|---|
| Depreciation | 68.8 | 68.8 | 68.5 | 69.8 | 69.6 |
|---|
| Profit before tax | 34.0 | 34.0 | 83.5 | 5.7 | -85.9 |
|---|
| Tax % | -3.5% | 3.5% | 18.3% | 82.6% | 4.6% |
|---|
| Net Profit | -68.8 | -68.8 | 98.2 | 10.5 | -88.7 |
|---|
| EPS in Rs | -6.31 | -6.31 | 0 | 0 | -7.74 |
|---|
Shareholding Distribution
Shareholding Pattern
Compounded Data
| Compounded Sales
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
114% |
| TTM: |
656% |
| Compounded Profit
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
37% |
| TTM: |
149% |
| Stock Price CAGR |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
0% |
| Compounded Sales
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
124% |
| TTM: |
740% |
| Compounded Profit
Growth |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
33% |
| TTM: |
130% |
| Stock Price CAGR |
| 10 Years: |
0% |
| 5 Years: |
0% |
| 3 Years: |
0% |
| 1 Year: |
0% |
